Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | SLS | SELLAS LIFE SCIENCES GROUP I | Healthcare | 41,788.0 | $617K | 0.14% | NEW | — | $14.76 | -11.2% |
| 42 | AKTS | AKTIS ONCOLOGY INC | Healthcare | 14,920.0 | $481K | 0.11% | NEW | — | $32.23 | -23.4% |
| 43 | — | SOLID BIOSCIENCES INC | — | 45,826.0 | $458K | 0.11% | NEW | — | $9.99 | — |
| 44 | GENB | GENERATE BIOMEDICINES INC | Financial Services | 26,430.0 | $446K | 0.10% | NEW | — | $16.87 | -4.0% |
| 45 | BIOA | BIOAGE LABS INC | Healthcare | 18,137.0 | $445K | 0.10% | NEW | — | $24.51 | -58.3% |
| 46 | DSGN | DESIGN THERAPEUTICS INC | Healthcare | 29,827.0 | $432K | 0.10% | NEW | — | $14.47 | +5.0% |
| 47 | MPLT | MAPLIGHT THERAPEUTICS INC | Healthcare | 11,791.0 | $423K | 0.10% | NEW | — | $35.84 | -67.6% |
| 48 | VOR | VOR BIOPHARMA INC | Healthcare | 22,785.0 | $419K | 0.10% | NEW | — | $18.41 | +26.7% |
| 49 | MANE | VERADERMICS INC | Healthcare | 3,406.0 | $419K | 0.10% | NEW | — | $122.94 | -11.1% |
| 50 | — | AVALO THERAPEUTICS INC | — | 22,168.0 | $410K | 0.10% | NEW | — | $18.48 | — |
| 51 | — | DAMORA THERAPEUTICS INC | — | 15,746.0 | $410K | 0.10% | NEW | — | $26.01 | — |
| 52 | — | OCULIS HOLDING AG | — | 29,504.0 | $409K | 0.10% | NEW | — | $13.87 | — |
| 53 | LXRX | LEXICON PHARMACEUTICALS INC | Healthcare | 170,415.0 | $409K | 0.10% | NEW | — | $2.40 | -1.5% |
| 54 | ANRO | ALTO NEUROSCIENCE INC | Healthcare | 15,239.0 | $402K | 0.09% | NEW | — | $26.39 | +28.2% |
| 55 | IMMX | IMMIX BIOPHARMA INC | Healthcare | 38,721.0 | $399K | 0.09% | NEW | — | $10.31 | +12.3% |
| 56 | SGP | SPYGLASS PHARMA INC | Healthcare | 17,744.0 | $395K | 0.09% | NEW | — | $22.26 | +16.4% |
| 57 | CADL | CANDEL THERAPEUTICS INC | Healthcare | 38,224.0 | $394K | 0.09% | NEW | — | $10.30 | +15.6% |
| 58 | — | ACHIEVE LIFE SCIENCE INC | — | 59,275.0 | $387K | 0.09% | NEW | — | $6.53 | — |
| 59 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 11,513.0 | $374K | 0.09% | NEW | — | $32.45 | +47.4% |
| 60 | — | FIRST TRACKS BIOTHERAPEUTICS | — | 18,549.0 | $373K | 0.09% | NEW | — | $20.12 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.3%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%